Cross‐sectional comparison of cardiovascular risk scores in people with HIV
HIV Medicine · 2025
DOI: 10.1111/hiv.70152 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift HIV Medicine, 2025. Verfasst von Maria Hernandez-Pereira und 7 weiteren Autor:innen. Beteiligte Einrichtung: Medicine and Life Sciences Department (MELIS), Universitat Pompeu Fabra, Barcelona, Spain. Hauptthemen laut MEDLINE: HIV Infections, Cardiovascular Diseases. Die Arbeit nennt 35 Literaturangaben.
Abstract (Originalsprache)
Introduction
People with HIV have an increased risk of cardiovascular disease (CVD). Despite this, commonly used CVD risk scores have been developed for the general population, which may underestimate risk in people with HIV. This study aims to evaluate the concordance of five risk prediction models (SCORE2, REGICOR, REGICOR 3.0, D:A:D reduced and D:A:D full) in a cohort of people with HIV.
Methods
This cross‐sectional study enrolled 246 participants aged 18–75 at a single centre in Barcelona, Spain. Demographic, clinical and laboratory data were collected to calculate 10‐year CVD risk using each model. Risk categories were compared using a chi‐square test followed by a post hoc analysis with Bonferroni's correction for multiple comparisons. Concordance was assessed using Lin's concordance correlation coefficient (CCC), and agreement was evaluated with Bland–Altman analysis.
Results
The risk category distribution differed significantly across models (χ 2 = 53.6, df = 12; p < 0.001). REGICOR classified most individuals as low‐risk (66.2%), whereas REGICOR 3.0 and D:A:D full identified more as very high‐risk (44.4% and 41.9%, respectively). Concordance was highest between D:A:D full and reduced (CCC = 0.82), good between SCORE2 and REGICOR (CCC = 0.78) and poor between most HIV‐specific and general population models (CCC < 0.5). Bland–Altman analyses revealed systematic bias, particularly between REGICOR and D:A:D full.
Conclusions
Cardiovascular risk scores showed limited concordance and poor interchangeability in people with HIV. The discrepancies between the general population and HIV‐specific models highlight the need for validated and HIV‐adapted tools to accurately assess CVD risk in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Medicine and Life Sciences Department (MELIS), Universitat Pompeu Fabra, Barcelona, Spain.
- Department of Internal Medicine. HIV-STD Division. Group for Research of Viral Infections (GRIV), Hospital del Mar Reserach Institute, Barcelona, Spain.
- Centro de Investigación Biomédica en Red Fragilidad y Envejecimiento Saludable (CIBERFES), Instituto de Salud Carlos III, Madrid, Spain.
- EAP Passeig Sant Joan, Institut Català de la Salut., Barcelona, Spain.
- Centro de investigación en Enfermedades Infecciosas (CIBERINFEC), Instituto de Salud Carlos III, Madrid, Spain.
ORCID-Profile: Robert Güerri-Fernandez
Zitieren
APA
Hernandez-Pereira, M., Du, J., Soldado-Folgado, J., Carbonell, I., Trenchs-Rodríguez, M., González-Mena, A., Garcia-Giralt, N., & Güerri-Fernandez, R. (2025). Cross‐sectional comparison of cardiovascular risk scores in people with HIV. HIV Medicine. https://doi.org/10.1111/hiv.70152
Vancouver
Hernandez-Pereira M, Du J, Soldado-Folgado J, Carbonell I, Trenchs-Rodríguez M, González-Mena A, et al. Cross‐sectional comparison of cardiovascular risk scores in people with HIV. HIV Medicine. 2025. doi:10.1111/hiv.70152
BibTeX
@article{HernandezPereira2025,
author = {Hernandez-Pereira, Maria and Du, Juan and Soldado-Folgado, Jade and Carbonell, Irene and Trenchs-Rodríguez, Marta and González-Mena, Alicia and Garcia-Giralt, Natalia and Güerri-Fernandez, Robert},
title = {Cross‐sectional comparison of cardiovascular risk scores in people with HIV},
journal = {HIV Medicine},
year = {2025},
doi = {10.1111/hiv.70152}
}
EUVIMED